Searched over 200M research papers
10 papers analyzed
These studies suggest ACE inhibitors are effective in treating cardiovascular and renal diseases, reducing mortality in myocardial infarction, managing hypertension, and delaying diabetic nephropathy, while also showing potential in treating diabetes-related complications and other conditions, though they may cause side effects like hypotension and increased potassium levels.
20 papers analyzed
Angiotensin-converting enzyme (ACE) inhibitors are a class of medications widely used in the treatment of cardiovascular and renal diseases. They work by inhibiting the enzyme responsible for the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing blood pressure . This article synthesizes the current research on ACE inhibitors, their applications, benefits, and potential side effects.
ACE inhibitors have shown significant benefits when administered early during acute myocardial infarction (MI). Large-scale trials have demonstrated that starting ACE inhibitor therapy within 36 hours of MI can reduce 30-day mortality rates by approximately 7%, with most benefits observed within the first week. This therapy is particularly beneficial for high-risk patients, such as those with anterior MI or elevated heart rates at entry.
ACE inhibitors are effective in treating hypertension by decreasing systemic vascular resistance without increasing heart rate, and they promote natriuresis . They also reduce mortality in patients with congestive heart failure and left ventricular dysfunction post-MI . Additionally, ACE inhibitors have been shown to stabilize plaques and inhibit ischemic events, further contributing to cardiovascular health.
ACE inhibitors are beneficial in delaying the progression of diabetic nephropathy. Clinical trials have shown that these medications significantly reduce the risk of developing macroalbuminuria in patients with microalbuminuria. This protective effect extends to patients with overt proteinuria and renal insufficiency, reducing the risk of doubling serum creatinine levels or developing end-stage renal disease.
Meta-analyses have indicated that ACE inhibitors and angiotensin receptor blockers (ARBs) can reduce the incidence of new-onset type 2 diabetes by 25%. This makes them a valuable option for patients with pre-diabetic conditions, such as metabolic syndrome, hypertension, or a family history of diabetes.
Given the side effects associated with synthetic ACE inhibitors, such as hypotension, renal insufficiency, and hyperkalemia, there is growing interest in natural ACE inhibitors derived from plants. Research has identified over 50 plant species with ACE-inhibitory activity, including Angelica keiskei and Momordica charantia. These natural inhibitors often have additional health benefits, such as antioxidant and anti-inflammatory properties, making them a promising alternative for managing diabetes-related complications.
While ACE inhibitors are generally well-tolerated, they can cause side effects such as persistent hypotension and renal dysfunction, particularly when combined with other medications like diuretics or nonsteroidal anti-inflammatory drugs (NSAIDs) . Hyperkalemia is another potential risk, especially in patients with renal insufficiency.
ACE inhibitors can interact with various cardiovascular and non-cardiovascular drugs. For instance, combining ACE inhibitors with potassium-sparing diuretics can lead to hyperkalemia, and their use with NSAIDs may increase the risk of acute renal failure. Additionally, there is some evidence linking ACE inhibitors with lithium toxicity and severe hypersensitivity reactions in certain patients.
ACE inhibitors play a crucial role in managing cardiovascular and renal diseases, offering significant benefits in reducing mortality and delaying disease progression. While synthetic ACE inhibitors are effective, natural alternatives from plants present a promising option with potentially fewer side effects. However, careful consideration of drug interactions and side effects is essential to maximize the therapeutic benefits of ACE inhibitors.
Most relevant research papers on this topic